This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bounds, S. J.
Right arrow Articles by Walters, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bounds, S. J.
Right arrow Articles by Walters, J. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2000, p. 2609-2614, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Fluoroquinolone Transport by Human Monocytes: Characterization and Comparison to Other Cells of Myeloid Lineage

Steven J. Bounds,1 Robin Nakkula,1 and John D. Walters1,2,*

Section of Periodontology, College of Dentistry,1 and Department of Molecular and Cellular Biochemistry, College of Medicine,2 The Ohio State University Health Sciences Center, Columbus, Ohio

Received 28 December 1999/Returned for modification 26 April 2000/Accepted 22 June 2000

Human monocytes transport and accumulate ciprofloxacin and other fluoroquinolones. Although little is known about the mechanisms of transport, we expected monocytes to be similar to other cells of myeloid lineage. In the present study, monocyte fluoroquinolone transport was characterized and compared to the corresponding transport pathways of human polymorphonuclear leukocytes (PMNs) and HL-60 cells. Ciprofloxacin transport by monocytes was saturable, temperature dependent, sodium independent, and relatively insensitive to pH. Quiescent monocytes transported ciprofloxacin with a Km of 171 µg/ml and a Vmax of 32.7 ng/min/106 cells. Adenine competitively inhibited ciprofloxacin transport by quiescent monocytes (Ki = 3.8 mM), but nucleosides had no significant inhibitory effect. In all of these respects, transport by monocytes was similar to that observed for quiescent PMNs and immature HL-60 cells. Unlike PMNs, however, monocytes and immature HL-60 cells did not exhibit dramatically enhanced ciprofloxacin transport when activated by phorbol myristate acetate (PMA). Consistent with this finding, HL-60 cells committed to granulocytic differentiation exhibited a significant component of PMA-inducible ciprofloxacin transport activity, while HL-60 cells committed to monocytic differentiation did not. In PMNs, the PMA-inducible component of transport appeared to be mobilized from a granule compartment, since its activity could be modulated by agents that enhance or inhibit stimulated degranulation. Thus, quiescent monocytes, PMNs, and HL-60 cells take up ciprofloxacin via similar energy-dependent transport mechanisms. Unlike granulocytes, monocytes do not express a second, higher-affinity pathway for ciprofloxacin accumulation when they are activated by PMA.

* Corresponding author. Mailing address: College of Dentistry, The Ohio State University, 305 West 12th Ave., Columbus, OH 43210. Phone: (614) 292-1322. Fax: (614) 292-2438. E-mail: walters.2{at}osu.edu.

Antimicrobial Agents and Chemotherapy, October 2000, p. 2609-2614, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Langer, O., Karch, R., Muller, U., Dobrozemsky, G., Abrahim, A., Zeitlinger, M., Lackner, E., Joukhadar, C., Dudczak, R., Kletter, K., Muller, M., Brunner, M. (2005). Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans. JNM 46: 1835-1841 [Abstract] [Full Text]  
  • Brunner, M., Langer, O., Dobrozemsky, G., Muller, U., Zeitlinger, M., Mitterhauser, M., Wadsak, W., Dudczak, R., Kletter, K., Muller, M. (2004). [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans. Antimicrob. Agents Chemother. 48: 3850-3857 [Abstract] [Full Text]  
  • Sarda, L., Cremieux, A.-C., Lebellec, Y., Meulemans, A., Lebtahi, R., Hayem, G., Genin, R., Delahaye, N., Huten, D., Le Guludec, D. (2003). Inability of 99mTc-Ciprofloxacin Scintigraphy to Discriminate Between Septic and Sterile Osteoarticular Diseases. JNM 44: 920-926 [Abstract] [Full Text]  
  • Yang, Q., Nakkula, R.J., Walters, J.D. (2002). Accumulation of Ciprofloxacin and Minocycline by Cultured Human Gingival Fibroblasts. JDR 81: 836-840 [Abstract] [Full Text]  
  • Cacchillo, D. A., Walters, J. D. (2002). Effect of Ciprofloxacin on Killing of Actinobacillus actinomycetemcomitans by Polymorphonuclear Leukocytes. Antimicrob. Agents Chemother. 46: 1980-1984 [Abstract] [Full Text]  
  • Sarda, L., Saleh-Mghir, A., Peker, C., Meulemans, A., Cremieux, A.-C., Le Guludec, D. (2002). Evaluation of 99mTc-Ciprofloxacin Scintigraphy in a Rabbit Model of Staphylococcus aureus Prosthetic Joint Infection. JNM 43: 239-245 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»